25
Participants
Start Date
July 25, 2017
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Magnetic Resonance Imaging (MRI)
Patients will undergo 2 different MRIs of the affected hip. Both MRIs assess hip cartilage degeneration. A contrast agent, Gadolinium, will be used to visualize cartilage during the MRI. The contrast agent is injected through an intravenous (a small plastic tube inserted into a vein in the patients' arm) before the MRI.
RECRUITING
Ottawa Hospital - General Campus, Ottawa
Lead Sponsor
Collaborators (1)
Zimmer Biomet
INDUSTRY
The Ottawa Hospital Academic Medical Association
OTHER
Ottawa Hospital Research Institute
OTHER